Complex effects of interferon-α on the cytokine network in HIV infection -: Possible contribution to immunosuppression

被引:28
作者
Stylianou, E [1 ]
Aukrust, P
Müller, F
Nordoy, I
Froland, SS
机构
[1] Natl Hosp Norway, Dept Med, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway
[2] Natl Hosp Norway, Dept Med, Internal Med Res Inst, N-0027 Oslo, Norway
关键词
HIV infection; IFN-alpha; IL-10; IL-12; IL-2;
D O I
10.1006/cyto.2000.0850
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since interleukin (IL-)2, IL-10 and IL-12 may contribute to the pathogenesis of human immune deficiency virus (HIV) infection we examined the effect of interferon (IFN)-alpha on these cytokines in cultures of various subsets of peripheral blood mononuclear cells (PBMC) in ten HIV-infected patients and ten healthy controls, Our main findings were: (1) IFN-alpha markedly enhanced IL-10 levels in a dose-dependent manner in both lipopolysaccharide (LPS)- and phytohaemagglutinin (PHA)-stimulated PBMC, as well as in anti-CD3- and anti-CD3/anti-CD28-stimulated T cells in both HIV-infected patients and controls, (2) In contrast, IFN-alpha had a downregulatory effect on IL-10 levels in Candida-stimulated PBMC,with particularly strong suppressive effect in HIV-infected patients. (3) Furthermore, IFN-alpha had a significant but modest stimulatory effect on IL-2 levels in PHA- and Candida-stimulated PBMC and anti-CD3-stimulated T cells. (4) IFN-alpha enhanced n-12 levels in a dose-dependent manner in LPS-stimulated PBMC in both patients and controls. Our findings that IFN-alpha markedly enhanced IL-10 and modestly enhanced IL-2 and IL-12, suggest a net immunosuppressive effect of IFN-alpha in HIV-infected patients, possibly contributing to progression of immunodeficiency in these patients. (C) 2001 Academic Press
引用
收藏
页码:56 / 62
页数:7
相关论文
共 38 条
[1]   Interferon-alpha stimulates production of interleukin-10 in activated CD4(+) T cells and monocytes [J].
Aman, MJ ;
Tretter, T ;
Eisenbeis, I ;
Bug, G ;
Decker, T ;
Aulitzky, WE ;
Tilg, H ;
Huber, C ;
Peschel, C .
BLOOD, 1996, 87 (11) :4731-4736
[2]  
Aukrust P, 1999, J IMMUNOL, V162, P1178
[3]   THE INTERFERONS - MECHANISMS OF ACTION AND CLINICAL-APPLICATIONS [J].
BARON, S ;
TYRING, SK ;
FLEISCHMANN, WR ;
COPPENHAVER, DH ;
NIESEL, DW ;
KLIMPEL, GR ;
STANTON, GJ ;
HUGHES, TK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (10) :1375-1383
[4]  
Chehimi J, 1995, RES IMMUNOL, V146, P605, DOI 10.1016/0923-2494(96)83038-0
[5]   Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy [J].
Chun, TW ;
Engel, D ;
Mizell, SB ;
Hallahan, CW ;
Fischette, M ;
Park, S ;
Davey, RT ;
Dybul, M ;
Kovacs, JA ;
Metcalf, JA ;
Mican, JM ;
Berrey, MM ;
Corey, L ;
Lane, HC ;
Fauci, AS .
NATURE MEDICINE, 1999, 5 (06) :651-655
[6]   RESTORATION OF HIV-SPECIFIC CELL-MEDIATED IMMUNE-RESPONSES BY INTERLEUKIN-12 IN-VITRO [J].
CLERICI, M ;
LUCEY, DR ;
BERZOFSKY, JA ;
PINTO, LA ;
WYNN, TA ;
BLATT, SP ;
DOLAN, MJ ;
HENDRIX, CW ;
WOLF, SF ;
SHEARER, GM .
SCIENCE, 1993, 262 (5140) :1721-1724
[7]   DETECTION OF 3 DISTINCT PATTERNS OF T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS - INDEPENDENCE OF CD4+ CELL NUMBERS AND CLINICAL STAGING [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
LUCEY, DR ;
VIA, CS ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1892-1899
[8]   ROLE OF INTERLEUKIN-10 IN T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC INDIVIDUALS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
CLERICI, M ;
WYNN, TA ;
BERZOFSKY, JA ;
BLATT, SP ;
HENDRIX, CW ;
SHER, A ;
COFFMAN, RL ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :768-775
[9]   A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1993, 14 (03) :107-110
[10]   CHANGES IN INTERLEUKIN-2 AND INTERLEUKIN-4 PRODUCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE INDIVIDUALS [J].
CLERICI, M ;
HAKIM, FT ;
VENZON, DJ ;
BLATT, S ;
HENDRIX, CW ;
WYNN, TA ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :759-765